Post-approval studies (Phase 4)Study completedNCT01266148
What this trial is testing
SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance
Who this might be right for
Renal Function and Chronic Allograft Vasculopathy
Novartis Pharmaceuticals 115